福建傲农生物科技集团股份有限公司第四届董事会第二十次会议决议公告

Group 1 - The company held its 20th meeting of the 4th Board of Directors on December 4, 2025, with all 9 directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][3][4] - The board approved the proposal to waive the notice period for this board meeting with unanimous consent [3][4] - The board approved a financing credit limit application for 2026, allowing the company to apply for up to RMB 3 billion from financial institutions, which requires shareholder approval [5][6] Group 2 - The board approved a proposal to provide guarantees for industry chain partners in 2026, with a maximum guarantee amount of RMB 300 million, also pending shareholder approval [7][11] - The company authorized the general manager to allocate guarantee amounts within the approved limit and to sign relevant legal documents [8][9][10] - The board approved mutual guarantees among the company and its subsidiaries for 2026, with specific limits based on the subsidiaries' debt ratios, pending shareholder approval [11][56] Group 3 - The board approved expected daily related party transactions with controlling shareholders for 2026, with 5 votes in favor and no opposition [13][15] - The board also approved expected daily related party transactions with other related parties for 2026, with 8 votes in favor [16][20] - The board approved a proposal for hedging activities in 2026, allowing for a maximum margin and premium limit of RMB 85 million, with a maximum contract value of RMB 550 million [22][23] Group 4 - The board approved the nomination of a new independent director to replace the resigned director, pending approval from the Shanghai Stock Exchange and shareholders [24][28] - The board agreed to convene the 4th extraordinary shareholders' meeting of 2025 at a later date, with details to be announced [25][26] Group 5 - The company plans to provide guarantees for industry chain partners in 2026, with a maximum guarantee amount of RMB 300 million, to support business operations and maintain supply chain stability [33][35] - As of October 31, 2025, the company had actual guarantees of RMB 93.96 million for industry chain partners, with overdue guarantees amounting to RMB 275.82 million [34][49] - The company will implement risk control measures, including requiring guarantees from the partners and regular financial reporting [44][45]